Typically, a CD62Lhigh OVA-specific CD8+ T cell will reside in lymphoid compartments, interact with its cognate antigen on an APC and proliferate to generate effector CD8+ T cells to circulate and combat the tumor [41]. The gene discussed is CD8A; the disease is neoplasm.